Jpmorgan Chase & CO Vaxcyte, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,427,760 shares of PCVX stock, worth $124 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,427,760

Previous 1,212,443 17.76%

Holding current value

$124 Million

Previous $91.6 Million 78.05%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$70.52 - $117.12 $15.2 Million - $25.2 Million	215,317 Added 17.76%	1,427,760 $163 Million
Q2 2024 Aug 12, 2024	BUY	$60.06 - $78.77 $3.04 Million - $3.99 Million	50,666 Added 4.36%	1,212,443 $91.6 Million
Q1 2024 May 10, 2024	BUY	$59.79 - $81.05 $45.2 Million - $61.3 Million	756,443 Added 186.62%	1,161,777 $79.4 Million
Q4 2023 Feb 12, 2024	SELL	$45.35 - $63.41 $10.5 Million - $14.7 Million	-232,387 Reduced 36.44%	405,334 $25.5 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $12.9 Million - $14.9 Million	281,312 Added 78.93%	637,721 $32.5 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $2.2 Million - $3.43 Million	63,513 Added 21.68%	356,409 $17.8 Million
Q1 2023 May 18, 2023	BUY	$36.27 - $47.2 $3.12 Million - $4.05 Million	85,884 Added 41.49%	292,896 $11 Million
Q1 2023 May 11, 2023	SELL	$36.27 - $47.2 $1.67 Million - $2.17 Million	-45,920 Reduced 18.16%	207,012 $7.76 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $1.5 Million - $3.49 Million	72,805 Added 40.42%	252,932 $12.1 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $2.95 Million - $3.88 Million	135,955 Added 307.79%	180,127 $4.32 Million
Q2 2022 Aug 11, 2022	BUY	$17.68 - $26.58 $307,278 - $461,960	17,380 Added 64.87%	44,172 $961,000
Q1 2022 May 11, 2022	BUY	$17.46 - $26.36 $111,569 - $168,440	6,390 Added 31.32%	26,792 $647,000
Q4 2021 Feb 10, 2022	SELL	$19.32 - $26.45 $109,254 - $149,574	-5,655 Reduced 21.7%	20,402 $486,000
Q3 2021 Nov 12, 2021	BUY	$20.26 - $26.97 $527,914 - $702,757	26,057 New	26,057 $661,000

Others Institutions Holding PCVX

# of Institutions

353

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.13B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Vaxcyte, Inc. Transaction History